ASHP Foundation pharmacy forecast 2020: strategic planning advice for pharmacy departments in hospitals and health systems

LC Vermeulen, MD Swarthout… - American Journal of …, 2020 - academic.oup.com
INTRODUCTION More than 30 years ago, the term patient-centered care was coined to shift
the focus of healthcare providers and health systems from diseases back to patients, and a …

Characterizing out-of-pocket payments and financial assistance for patients prescribed abiraterone and enzalutamide at an academic cancer center specialty …

AY Jeong, EB Schwartz, AR Roman… - JCO Oncology …, 2022 - ascopubs.org
PURPOSE: Abiraterone and enzalutamide are commonly used oral cancer therapies for
patients with prostate cancer, both with potentially high out-of-pocket costs for patients. We …

Targeting financial toxicity in oncology specialty pharmacy at a large tertiary academic medical center

JL Farano, HM Kandah - Journal of Managed Care & Specialty Pharmacy, 2019 - jmcp.org
BACKGROUND: Patients with cancer often face financial toxicity. They may face financial
distress because of high out-of-pocket costs that in turn can result in delays in treatment …

Factors Associated with Insured Children's Use of Physician Visits, Dentist Visits, Hospital Care, and Prescribed Medications in the United States: An Application of …

TC Cheng, CC Lo - International Journal of Environmental Research and …, 2024 - mdpi.com
This study is the first to examine factors in the utilization of physician services, dentist
services, hospital care, and prescribed medications focusing exclusively on insured children …

Assessment of medication adherence after enrollment in a health system funded medication assistance program for patients with diabetes

L Franck, A Donovan, M Kellison… - Journal of the American …, 2023 - Elsevier
Background High costs for patients' medications decrease medication access and
adherence which contributes to poor clinical outcomes. Numerous medication assistance …

Copayment reduction voucher utilization and associations with medication persistence and clinical outcomes: findings from the ARTEMIS trial

AC Fanaroff, ED Peterson, LA Kaltenbach… - … Quality and Outcomes, 2020 - Am Heart Assoc
Background: Cost is frequently cited as a barrier to optimal medication use, but the extent to
which copayment assistance interventions are used when available, and their impact on …

Access to medications among adults with type 2 diabetes using pharmacy-or clinic-based medication assistance programs: A systematic review

LM Ward, DB Pendergrass, CC Chima… - Journal of the American …, 2020 - Elsevier
Objective The purpose of this systematic review was to assess the literature regarding
access to, and utilization of medication for type 2 diabetes (T2D) and pre-post improvements …

How pharmacy benefit managers add to financial toxicity: The copay accumulator program

C Nabhan, EG Phillips, BA Feinberg - JAMA oncology, 2018 - jamanetwork.com
The sustained rise of prescription drug costs has continued to receive considerable
attention, with recent blame being directed toward the pharmaceutical supply chain …

The Impact of Intestinal Dysfunction on the Incidence of Neuromyelitis Optica Spectrum Disorder

DT Foley - 2023 - search.proquest.com
Abstract Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare, debilitating
neurodegenerative disorder resulting in significant patient morbidity. If left untreated …

The financial effect of medicare coverage design and safety net options for cancer care

SS Bethay, MJ Travis, SK Batt, SH Bochenek… - Journal of Managed …, 2020 - jmcp.org
BACKGROUND: National spending on specialty medications accounted for approximately
193billionin2016.ThecoveragedesignforMedicarePartsBand…,whichmayprohibitpatientsfromstartingormai …